Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/28953


Interferons - State-of-the-Science and Strategic Opportunities


Description: The world market for interferons was valued at US$2.3 billion in 1999. Interferon alfa accounted for 72% of the market mainly through the antiviral indications for hepatitis. Interferon beta, which was the fastest growing segment of the market, accounted for 24% by the end of the year. The interferon market is application dependent with different indications approved in different markets. The impact of launch of interferon in a market is not as important as the impact of its approval for a main-line indication. This makes interferons a multiple niche market accessible to small players. Although the market is currently controlled by large companies, the success of the launch Avonex by Biogen symbolizes the ease with which a small company can exploit a biopharmaceutical niche based on an indication approval. The success of interferons symbolize the success of hope and scientific hype over reason. The product has a high side effect profile and a low efficacy profile. However, performing clinical trials in small number of patients can yield statistically creative results that lead to an approval for a relapsing disease like hairy cell leukemia or MS. Develop several small niches in different areas and you have a product generating hundreds of millions of dollars every year. Interferons, State-of-the-Science and Strategic Opportunities is a strategic business report that assesses both the technology status and the competitive landscape of the world interferons market. The report examines both the US and the European markets in detail, profiles leading products and companies and offer revenue forecasts to the year 2005. The report assesses the market attractiveness and potential and evaluates different options for market entry.


Contents:

I. Executive Briefing
II. State of the Science
A. Introduction
B. Structure, Production & Function
C. Interferon alfa
D. Interferon beta
E. Interferon gamma.
F. Role in Combating viral infections
G. Role in Halting cancer propagation
H. Role in Reversing auto-immune disorders
I. Recent Application Trends
III. The Products
A. Current Products On The Market
B. Products Launch Sequence
C. Dosage & Formulations
D. Decision Making & Dispensing Dynamics
E. Present Pricing Strategy
F. Reimbursement Status
IV. Current Market Situation
A. Market Size & Growth Rates

1. The World Market
2. The US Market
3. European Markets

B. Leading Market Participants
C. Market Shares

1. Schering Plough
2. Schering AG
3. Roche
4. Biogen
5. Glaxo-Wellcome
6. Boehringer Ingelhiem
7. Diiatch
8. Sumitomo
9. Shionogi
10. Immunomax
11. Serono
12. Sigma Tau
13. Genentech

V. Future Market Trends
A. Main Vectors of Change
B. Patient Pool Trends
C. Product Pricing Trends
D. The Market in 2005
VI. Strategic Opportunities
A. Market Attractiveness
B. Opportunities in Super Generics
C. Opportunities in New Product Development
D. Opportunities in Product Synergy




Ordering: Order Online - visit http://www.researchandmarkets.com/reports/28953

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 26/11/2009 14:15:08
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
Interferons - State-of-the-Science and Strategic Opportunities
Web Address:
http://www.researchandmarkets.com/reports/28953
Office Code:
OC8HJNMPMSTQQ

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Hard Copy €519.00 + EUR€ 50.00 Shipping/Handling *
Electronic €305.00
Electronic - Site License €1,926.00
* Shipping/Handling is only charged once per order.


Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 26/11/2009 14:15:08

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)